Singapore commission blocks IHH’s proposed buy


Purchase of RadLink will result in ‘a substantial lessening of competition’.

PETALING JAYA: In a sign of the increasing enforcement of anti-competitive regulations in this part of the world, IHH Healthcare Bhd’s plan to buy out a Singapore-based diagnostic and molecular imaging service provider has been blocked by the Competition Commission of Singapore (CCS) – the first such move by the regulator there.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , IHH , Radlink , Singapore

   

Next In Business News

Oil falls on prospect of higher-for-longer US rates
Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
Wellness a top priority
InNature diversifies into the F&B industry
Tolerance for a cheaper yuan may be temporary
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
China’s push for greener aluminium hit by erratic rains, power cuts

Others Also Read